COMMUNIQUÉS West-GlobeNewswire

CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies
10/03/2025
A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; p=0.003 vs. placebo) on the primary outcome measure, change from baseline in [...]
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
10/03/2025
Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy MyPEAK-1 Cohort 1 Data Accepted for Late-Breaker Presentation at the [...]
Mineralys Therapeutics Announces Proposed Public Offering of Common Stock
10/03/2025
RADNOR, Pa., March 10, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD [...]
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
10/03/2025
NEWTON, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers [...]
There Is Hope for American Medicine, Writes President of the Association of American Physicians and Surgeons (AAPS)
10/03/2025
TUSCON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- Hope, a very small word with a very large impact, is powerful. Without hope, all is futility, writes Erika L. LeBaron, D.O., M.S.N ., in the spring issue of the Journal [...]
Defenses against Sham Peer Review Discussed in the Journal of American Physicians and Surgeons
10/03/2025
TUSCON, Ariz. , March 10, 2025 (GLOBE NEWSWIRE) -- False accusations of being a “disruptive physician” can ruin a physician’s career as well as cause moral injury that damages the very core of a physician’s identity, [...]
ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER
10/03/2025
Presentations highlight relationship between semaglutide and blood markers of gene modification age predictors, gut bacteria, heart and metabolic effects, and fat in the liver LOS ANGELES, March 10, 2025 (GLOBE NEWSWIRE [...]
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
10/03/2025
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 IMC-M113V was well tolerated, with no dose-limiting toxicities Signals of dose-dependent [...]
Long-term Brain Effects from COVID Vaccine Discussed in the Journal of American Physicians and Surgeons
10/03/2025
TUCSON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- Rushed into production, the mRNA COVID vaccine was administered to 100 million people too soon to see any possible long-term neurologic effects, particularly in babies [...]
Mental Health and the COVID Vaccine Discussed in the Journal of American Physicians and Surgeons
10/03/2025
TUCSON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- In the wake of the COVID pandemic, many persons suffered severe mental health problems, which could have resulted from many causes, writes Jane Orient, M.D. , in the [...]
EssilorLuxottica: 2024 Universal Registration Document filed
10/03/2025
2024 Universal Registration Document filed Paris, France (10 March 2025) – EssilorLuxottica announces the availability of its 2024 Universal Registration Document, in accordance with applicable regulation. The French [...]
EssilorLuxottica: Mise à disposition du Document d’enregistrement universel 2024
10/03/2025
Mise à disposition du Document d’enregistrement universel 2024 Paris, France (10 mars 2025) - EssilorLuxottica annonce la mise à disposition de son Document d’enregistrement universel 2024 dans les conditions requises [...]
Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025
10/03/2025
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES 10 MARCH 2025 at 19.00 EET Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025 In accordance with a decision by the Board of [...]
MSInsight Announces €1.6 Million in Seed Fundraising to Revolutionize MSI Cancer Diagnosis
10/03/2025
Press Release Paris, March 12, 2025 – MSInsight, an innovative start-up specializing in precision medicine in oncology, announces the successful completion of its €1.6 million seed funding round. This fundraising was [...]
MSInsight annonce une levée de fonds d’amorçage de 1,6 M€ pour révolutionner le diagnostic des cancers MSI
10/03/2025
Communiqué de presse Paris, le 12 mars 2025 – MSInsight, start-up innovante spécialisée dans la médecine de précision en oncologie, annonce la réussite de son tour de financement d’amorçage d'un montant de 1,6 million d [...]
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO
10/03/2025
Vaccine is intended to stimulate T cell responses against targets across the entire genome of the selected virus, similar to company’s lead product candidate TVGN 489, to mitigate the risk posed by mutations. Approach [...]
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board
10/03/2025
Psyence Group settles Debt for Shares TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group " or the " Company ") (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd [...]
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
10/03/2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of Orthopaedic Surgeons Annual [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
10/03/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 10 March 2025 at 17.00 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

Pages